AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Carasent AB

Share Issue/Capital Change Dec 16, 2025

10136_rns_2025-12-16_1e6a8d75-1185-433c-ac2c-6c020284270e.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Carasent AB (publ): Carasent's holding of own shares exceeds five percent

Carasent AB (publ) ("Carasent") hereby announces, in accordance with Chapter 4, Section 18 of the Swedish Financial Instruments Trading Act (1991:980), that the company's holding of own shares as of 16 december 2025 has exceeded the threshold of 5 percent of all shares and voting rights in the company.

As of the date of this press release, Carasent's total holding of own shares amounts to 3,656,092 shares (3,556,092 shares prior to today's trade and 100,000 shares repurchased during the day), corresponding to 5.06 percent of the total number of shares and voting rights in the company. The total number of shares and voting rights in Carasent, including the company's own shares, amounts to 72,324,781.

The threshold has been exceeded as a result of repurchases carried out under Carasent's share buyback program of up to SEK 150 million, which was announced on 9 July 2025, based on the authorization granted by the Annual General Meeting on 23 April 2025. The program may run until the 2026 Annual General Meeting at the latest and the company's holding may not exceed 10 percent of the total number of outstanding shares at any given time.

The purpose of the buy-back program is to adjust Carasent's capital structure and to enable the company to finance acquisitions with its own shares.

For further information, please contact:

Daniel Öhman, CEO, Tel: +46 70-855 37 07 Svein Martin Bjørnstad, CFO, Tel: +47 979 69 493

This information is information that Carasent AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication on 16 december 2025 at 14:44 CET.

Talk to a Data Expert

Have a question? We'll get back to you promptly.